Concepedia

Michelle A. Hering

MA

Statistics

Publications

3

Citations

519

H-Index

3

Active since

2005

Affiliations

Seagen (United States)(Current)

Michelle A. Hering is an author at Seagen (United States) specializing in oncology, antibody-drug conjugates, and molecular oncology.

Publications per year

2005–2007

3

Publications

3

<i>In vivo</i>Drug-Linker Stability of an Anti-CD30 Dipeptide-Linked Auristatin Immunoconjugate

Russell J. Sanderson, Michelle A. Hering, Stephanie James et al. · Clinical Cancer Research · 2005 · 280 citations · Full text

, , +17

Lymphocyte Activation Antigen CD70 Expressed by Renal Cell Carcinoma Is a Potential Therapeutic Target for Anti-CD70 Antibody-Drug Conjugates

Che‐Leung Law, Kristine A. Gordon, Brian E. Toki et al. · Cancer Research · 2006 · 152 citations

, , +16

Antibody targeting of B-cell maturation antigen on malignant plasma cells

Maureen C. Ryan, Michelle A. Hering, D. W. Peckham et al. · Molecular Cancer Therapeutics · 2007 · 87 citations · Full text

, , +17

1–3 of 3